Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My Cart

Main menu

  • Home
  • Articles
    • Archive
  • About the Journal
    • About CVI
    • For Librarians
    • For Advertisers
    • FAQ
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Clinical and Vaccine Immunology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Archive
  • About the Journal
    • About CVI
    • For Librarians
    • For Advertisers
    • FAQ
MICROBIAL IMMUNOLOGY

Epitope-Blocking Enzyme-Linked Immunosorbent Assay for Detection of Antibodies to Ross River Virus in Vertebrate Sera

Nidia M. M. Oliveira, Annette K. Broom, John S. Mackenzie, David W. Smith, Michael D. A. Lindsay, Brian H. Kay, Roy A. Hall
Nidia M. M. Oliveira
1Arbovirus Surveillance and Research Laboratory, Department of Microbiology, The University of Western Australia, Nedlands, Western Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Annette K. Broom
1Arbovirus Surveillance and Research Laboratory, Department of Microbiology, The University of Western Australia, Nedlands, Western Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John S. Mackenzie
2School of Molecular and Microbial Sciences, The University of Queensland, Brisbane, Queensland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David W. Smith
3Division of Health Sciences, The Western Australian Centre for Pathology and Research, Queen Elizabeth II Medical Centre, Nedlands, Western Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael D. A. Lindsay
1Arbovirus Surveillance and Research Laboratory, Department of Microbiology, The University of Western Australia, Nedlands, Western Australia
4Mosquito-Borne Disease Control Branch, Western Australian Department of Health, Perth, Western Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brian H. Kay
5Queensland Institute of Medical Research and Australian Centre for International and Tropical Health and Nutrition, Brisbane, Queensland, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roy A. Hall
2School of Molecular and Microbial Sciences, The University of Queensland, Brisbane, Queensland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: roy.hall@uq.edu.au
DOI: 10.1128/CVI.00035-06
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

We describe the development of an epitope-blocking enzyme-linked immunosorbent assay (ELISA) for the sensitive and rapid detection of antibodies to Ross River virus (RRV) in human sera and known vertebrate host species. This ELISA provides an alternative method for the serodiagnosis of RRV infections.

Ross River virus (RRV) is a mosquito-borne alphavirus that is endemic in Australia and Papua New Guinea. The primary hosts of the virus include humans, kangaroos, wallabies, and horses (2, 11, 12, 15). RRV is the major etiological agent of epidemic polyarthritis in humans, which is characterized by severe arthritis with possible development of a rash and mild fever or chills and for which there is no specific treatment. Effective surveillance of virus activity in its natural transmission cycle, with appropriate warnings to the public, is the best measure available for minimizing this disease. Traditionally, hemagglutination inhibition (HI), neutralization, and immunofluorescence assays (2, 7, 13) have been the means for detecting RRV antibodies in both human and animal sera. Enzyme-linked immunosorbent assay (ELISA) has also been used to specifically detect RRV immunoglobulin M in human sera (6, 17). Previously, epitope-blocking assays were developed for sensitive and specific detection of seroconversions to the medically important flaviviruses Murray Valley encephalitis virus (8, 9) and West Nile virus (3, 4, 10) in avian and mammalian sera. In this study, an epitope-blocking ELISA was developed for the rapid detection of RRV antibodies in both animal and human sera to improve the efficiency of seroepidemiological studies.

This study used seven isolates of RRV, obtained over 30 years from different regions in Australia, as well as the closely related alphaviruses Chikungunya virus, Getah virus, Barmah Forest virus (BFV), Semliki Forest virus, and Sindbis virus (Table 1). RRV ELISA antigen was produced by propagation of the prototype RRV strain T48 on Vero cells in serum-free medium. Virus supernatant was clarified at 4,000 × g for 15 min at 4°C and stored in 1-ml aliquots at −80°C. Polyclonal antisera were produced in New Zealand half-lop rabbits by intravenous inoculation with 50 μg purified virus/200 μl phosphate-buffered saline and bled at day 14 postinoculation (Table 1). Hyperimmune antisera were not used due to the enhanced cross-reactions observed after multiple immunizations. Nonreactive control sera were collected from nonimmune animals. Clinical samples of human sera (PathCentre, Western Australia [WA] State Health Department, QE11 Medical Centre, Nedlands, Australia) and samples from kangaroos and horses were collected as part of an ongoing seroepidemiological study of RRV in parts of WA (13). These samples were previously tested for RRV antibodies by standard assays (1, 6, 7). Titers are presented as the reciprocal of the highest dilution of antibody to completely neutralize or inhibit RRV. In developing the epitope-blocking ELISA, the protocol described by Hall et al. (9) was adapted. U-bottomed 96-well polyvinyl chloride plates were coated with an optimal concentration of RRV ELISA antigen at 50 μl/well under appropriate biological containment and incubated overnight at 4°C in coating buffer (0.1 M carbonate/bicarbonate, pH 9.6). Antigen-coated plates were washed twice with wash buffer, and nonspecific sites were blocked with 100 μl blocking buffer (0.05 M Tris, 1 mM EDTA, 0.15 M NaCl, 0.05% [vol/vol] Tween 20, 0.2% [wt/vol] casein, pH 8.0) for 1 hour at room temperature (RT). Reference or test sera were added (50 μl/well) in duplicate at dilutions of 1/10 and 1/100 in blocking buffer and incubated for 2 hours at RT. Nonimmune chicken and rabbit sera were used as nonreactive controls. Without removal of serum, 50 μl of monoclonal antibody (MAb) (hybridoma culture supernatant diluted in blocking buffer) was added to each well, and after gentle agitation the plates were incubated at RT for 1 hour. Plates were washed four times and bound MAb detected by incubation with horseradish peroxidase-conjugated goat anti-mouse immunoglobulin (Bio-Rad) diluted in blocking buffer for 1 hour at RT. Plates were washed six times and enzyme activity visualized by the addition of 100 μl substrate solution [1 mM 2,2′-azinobis(3-ethylbenzthiazolinesulfonic acid] (ABTS) and 3 mM H2O2 in a citrate/phosphate buffer, pH 4.2). Quantitative results were determined by measuring the optical density (OD) at 405 nm, and percent inhibitions were calculated as 100 − [OD (test)/OD (negative control) × 100]. A threshold of 20% inhibition by the test serum was considered “positive” for RRV antibodies (9).

Three MAbs (3B2, G8, and B10), produced to the E2 protein of reference RRV strains as previously described (5, 16), were assessed in the assay. The most sensitive and specific reactions were obtained using MAb 3B2, which was specifically inhibited from binding to RRV antigen in the presence of antisera to all seven reference RRV strains (Table 1). Thus, unless there is a major antigenic shift in circulating RRV strains, detection of RRV antibodies directed to this immunodominant epitope should be effective. Furthermore, using this MAb, there was no cross-reactivity (<20% MAb inhibition) with rabbit antisera to the closely related alphaviruses (Table 1). The results with field samples of kangaroo and horse sera showed ELISA to be as sensitive (100%) and specific (95%) as conventional neutralization for detecting RRV antibodies in these known vertebrate hosts (Table 2).

When used to test a panel of clinical RRV-positive human samples, the blocking ELISA exhibited 97% sensitivity and 98% specificity for the detection of antibody (Tables 3 and 4). This assay's ability to differentiate between seroconversion to BFV and RRV is also important, because both viruses are causative agents of epidemic polyarthritis and they circulate in the same geographical region (13). The acute-phase samples that were negative by ELISA (5007112N and 5028481W) (Table 3) may represent individuals who fail to mount a detectable immune response to the 3B2 epitope early in infection, as the convalescent-phase paired sample to 507112N (5013418) (Table 4) was subsequently shown to be positive by ELISA. The definitive criterion for confirming a recent viral infection is a fourfold or greater increase in the neutralization or HI titer of a paired serum sample (14). We propose that a twofold or greater increase in the percent inhibition of MAb by paired serum samples in the blocking ELISA be used as the criterion for serodiagnosis of recent RRV infection (Table 4). Past seroconversions to RRV could be identified by a greater than 20% inhibition by a single serum sample (Table 3) (9). In conclusion, the RRV epitope-blocking ELISA described in this paper provides a feasible alternative for the rapid diagnosis of clinical human RRV infection and for application in preclinical serosurveillance of susceptible vertebrate hosts (12, 15).

View this table:
  • View inline
  • View popup
TABLE 1.

Neutralization titer and percent inhibition of MAb binding in the epitope-blocking ELISA produced by rabbit antisera to reference RRV strains and other alphaviruses

View this table:
  • View inline
  • View popup
TABLE 2.

Comparison of the specificity and sensitivity of the epitope-blocking ELISA with virus neutralization to detect anti-RRV antibodies in kangaroo and horse sera

View this table:
  • View inline
  • View popup
TABLE 3.

Comparison of the RRV-specific epitope-blocking ELISA and standard diagnostic techniques for detection of antibodies to RRV in human seraa

View this table:
  • View inline
  • View popup
TABLE 4.

Comparison of the epitope-blocking ELISA and standard diagnostic techniques for the detection of RRV antibodies in paired serum samplesa

ACKNOWLEDGMENTS

We thank Brad Blitvich for reviewing the manuscript and Ian Marshall, Debbie Phillips, and Ian Fanning for providing virus isolates.

These studies were supported by a grant from the Western Australian Health Department, and N. M. M. Oliveira was funded by a scholarship from the Queensland Institute of Medical Research.

FOOTNOTES

    • Received 27 January 2006.
    • Returned for modification 6 March 2006.
    • Accepted 5 May 2006.
  • Copyright © 2006 American Society for Microbiology

REFERENCES

  1. 1.↵
    Aaskov, J. G., and C. E. A. Davies. 1979. An immunofluorescence assay for human antibodies to Ross River virus. J. Immunol. Methods25:37-41.
    OpenUrlPubMed
  2. 2.↵
    Aaskov, J. G., J. R. E. Fraser, and D. A. Daglish. 1981. Specific and nonspecific immunological changes in epidemic polyarthritis patients. Aust. J. Exp. Biol. Med. Sci.59:599-608.
    OpenUrlCrossRefPubMed
  3. 3.↵
    Blitvich, B. J., N. L. Marlenee, R. A. Hall, C. A. Calisher, R. A. Bowen, J. T. Roehrig, N. Komar, S. A. Langevin, and B. J. Beaty. 2003. Epitope-blocking enzyme-linked immunosorbent assays for the detection of serum antibodies to West Nile virus in multiple avian species. J. Clin. Microbiol.41:1041-1047.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    Blitvich, B. J., R. A. Bowen, N. L. Marlenee, R. A. Hall, M. L. Bunning, and B. J. Beaty. 2003. Epitope-blocking enzyme-linked immunosorbent assays for the detection of West Nile virus antibodies in domestic mammals. J. Clin. Microbiol.41:2676-2679.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    Broom, A. K., R. A. Hall, C. A. Johanse, N. Oliveira, M. A. Howard, M. D. Lindsay, B. H. Kay, and J. Mackenzie 1998. Indentification of Australian arboviruses in inoculated cell cultures using monoclonal antibodies in ELISA. Pathology 30:286-288.
  6. 6.↵
    Carter, I. W. J., L. D. Smythe, J. R. E. Fraser, N. D. Stallman, and M. J. Cloonan. 1985. Detection of Ross River virus immunoglobulin M antibodies by enzyme linked immunosorbent assay using antibody class capture and comparison with other methods. Pathology17:503-508.
    OpenUrlPubMed
  7. 7.↵
    Clarke, D. H., and J. Casals. 1958. Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses. Am. J. Trop. Med. Hyg.7:561-573.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    Hall, R. A., A. K. Broom, A. Hartnett, M. J. Howard, and J. S. Mackenzie. 1992. Specific monitoring of flavivirus infections in man and sentinel animals by epitope blocking ELISA. Arbovirus Res. Aust.6:155-158.
    OpenUrl
  9. 9.↵
    Hall, R. A., A. K. Broom, A. C. Hartnett, M. J. Howard, and J. S. Mackenzie. 1995. Immunodominant epitopes on the NS1 protein of MVE and KUN viruses serve as targets for a blocking ELISA to detect virus specific antibodies in sentinel animal serum. J. Virol. Methods51:201-210.
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    Hall, R. A. 2000. The emergence of West Nile virus: the Australian connection. Viral Immunol.13:447-461.
    OpenUrlPubMed
  11. 11.↵
    Kay, B. H., and H. A. Standfast. 1987. Ecology of arboviruses and their vectors in Australia, p. 1-36. In K. F. Harris (ed.), Current topics in vector research, vol. 1. Springer-Verlag, New York, N.Y.
    OpenUrl
  12. 12.↵
    Kay, B. H., and J. G. Aaskov. 1989. Ross River virus (epidemic polyarthritis), p. 93-112. In T. P. Monath (ed.), The arboviruses: epidemiology and ecology, vol. 4. CRC Press Inc., Boca Raton, Fla.
    OpenUrl
  13. 13.↵
    Lindsay, M. D. 1995. Ecology and epidemiology of Ross River virus in Western Australia. Ph.D. thesis. The University of Western Australia, Nedlands, Australia.
  14. 14.↵
    Mackenzie, J. S., A. K. Broom, C. H. Calisher, M. J. Cloonan, A. L. Cunningham, C. Gibson, L. Heuston, M. D. Lindsay, I. D. Marshall, D. A. Phillips, R. C. Russell, J. Sheridan, D. W. Smith, L. Smythe, T. Vitarana, and D. Worwick. 1992. Diagnosis and reporting for arbovirus infections in Australia. Arbovirus Res. Aust.6:89-93.
    OpenUrl
  15. 15.↵
    Marshall, I. D., and J. A. R. Miles. 1984. Ross River virus and epidemic polyarthritis, p. 31-56. In K. F. Harris (ed.), Current topics in vector research, vol. 2. Springer-Verlag, New York, N.Y.
    OpenUrl
  16. 16.↵
    Oliveira, N. M., R. Hall, A. Broom, M. Lindsay, R. Weir, B. Kay, and J. Mackenzie. 1997. Epitope analysis of Ross River virus using monoclonal antibodies. Arbovirus Res. Aust.7:201-207.
    OpenUrl
  17. 17.↵
    Oseni, R. A., M. D. Donaldson, D. A. Daglish, and J. G. Aaskov. 1983. Detection by ELISA of IgM antibodies to Ross River virus in serum from patients with suspected epidemic polyarthritis. Bull. W. H. O.61:703-708.
    OpenUrlPubMed
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
Epitope-Blocking Enzyme-Linked Immunosorbent Assay for Detection of Antibodies to Ross River Virus in Vertebrate Sera
Nidia M. M. Oliveira, Annette K. Broom, John S. Mackenzie, David W. Smith, Michael D. A. Lindsay, Brian H. Kay, Roy A. Hall
Clinical and Vaccine Immunology Jul 2006, 13 (7) 814-817; DOI: 10.1128/CVI.00035-06

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Email

Thank you for sharing this Clinical and Vaccine Immunology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Epitope-Blocking Enzyme-Linked Immunosorbent Assay for Detection of Antibodies to Ross River Virus in Vertebrate Sera
(Your Name) has forwarded a page to you from Clinical and Vaccine Immunology
(Your Name) thought you would be interested in this article in Clinical and Vaccine Immunology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Epitope-Blocking Enzyme-Linked Immunosorbent Assay for Detection of Antibodies to Ross River Virus in Vertebrate Sera
Nidia M. M. Oliveira, Annette K. Broom, John S. Mackenzie, David W. Smith, Michael D. A. Lindsay, Brian H. Kay, Roy A. Hall
Clinical and Vaccine Immunology Jul 2006, 13 (7) 814-817; DOI: 10.1128/CVI.00035-06
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Alphavirus Infections
Antibodies, Viral
Enzyme-Linked Immunosorbent Assay
epitopes
Ross River virus

Related Articles

Cited By...

About

  • About CVI
  • For Librarians
  • For Advertisers
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • Submit a Manuscript to mSphere

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 1556-6811; Online ISSN: 1556-679X